NEU neuren pharmaceuticals limited

Ann: Update - Notification of buy-back - NEU, page-34

  1. 22 Posts.
    lightbulb Created with Sketch. 3
    thanks htae39. UBS's bias against neu is very obvious based on your data. I dont understand the logic behind this type of trading. I can understand a company wanting to reduce or opt out of their position and therefore selling at a loss...but i dont get the continued buying and selling at a loss. Has anyone had any personal experience with this type of trading? There has been been discussions that this is a pattern generally associated with a forthcoming bidding process but is this the case? If it is and there are prior evidences that mimic historical behaviour then is this legal? It doesnt seem fair that companies can use their large funds to manipulate a stock in this manner to their advantage.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.574B
Open High Low Value Volume
$12.82 $13.05 $12.53 $5.449M 425.4K

Buyers (Bids)

No. Vol. Price($)
11 369 $12.84
 

Sellers (Offers)

Price($) Vol. No.
$12.85 1217 11
View Market Depth
Last trade - 15.41pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.